PREVENTION OF PRIMARY PROSTATE-CANCER IN LOBUND-WISTAR RATS BY N-(4-HYDROXYPHENYL)RETINAMIDE

被引：0
|
作者：
POLLARD, M [1 ]
LUCKERT, PH [1 ]
SPORN, MB [1 ]
机构：
[1] NCI,CHEMOPREVENT LAB,BETHESDA,MD 20892
来源：
CANCER RESEARCH | 1991年 / 51卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We report for the first time that a synthetic retinoid, N-(4-hydroxyphenyl) retinamide, can prevent the development of both primary and metastatic tumors in an animal model of metastasizing primary prostate cancer. Prostatic adenocarcinomas were induced in high incidence in Lobund-Wistar rats by initiation with methylnitrosourea i.v. and promotion with testosterone. Feeding of N-(4-hydroxyphenyl)retinamide to these rats during the latency period markedly diminished the final incidence of both primary and metastatic prostate carcinomas.
引用
收藏
页码：3610 / 3611
页数：2
相关论文
共 50 条
  • [41] N-(4-HYDROXYPHENYL)-ALL-TRANS-RETINAMIDE PHARMACOKINETICS IN FEMALE RATS AND MICE
    HULTIN, TA
    MAY, CM
    MOON, RC
    DRUG METABOLISM AND DISPOSITION, 1986, 14 (06) : 714 - 717
  • [42] N-(4-HYDROXYPHENYL)RETINAMIDE (4-HPR) LOWERS PLASMA RETINOL LEVELS IN RATS
    FORMELLI, F
    CARSANA, R
    COSTA, A
    MEDICAL SCIENCE RESEARCH-BIOCHEMISTRY, 1987, 15 (13-14): : 843 - 844
  • [43] Dietary prevention of hormone refractory prostate cancer in Lobund-Wistar rats: A review of studies in a relevant animal model
    Pollard, Morris
    Suckow, Mark A.
    COMPARATIVE MEDICINE, 2006, 56 (06) : 461 - 467
  • [44] Prevention of spontaneous prostate-related cancer in Lobund-Wistar rats by a soy protein isolate/isoflavone diet
    Pollard, M
    Wolter, W
    PROSTATE, 2000, 45 (02): : 101 - 105
  • [45] EFFECTS OF PRETREATMENT WITH THE RETINOID N-(4-HYDROXYPHENYL)-ALL-TRANS-RETINAMIDE AND PHENOBARBITAL ON THE DISPOSITION AND METABOLISM OF N-(4-HYDROXYPHENYL)-ALL-TRANS-RETINAMIDE IN MICE
    HULTIN, TA
    MCCORMICK, DL
    MAY, CM
    MOON, RC
    DRUG METABOLISM AND DISPOSITION, 1988, 16 (06) : 783 - 788
  • [46] RESTORATION OF APOPTOSIS IN HUMAN PROSTATE CELLS BY TREATMENT WITH N-(4-HYDROXYPHENYL) RETINAMIDE (4-HPR)
    HSIEH, TC
    NG, CY
    MALLOUH, C
    WU, JM
    FASEB JOURNAL, 1995, 9 (06): : A1379 - A1379
  • [47] N-(4-hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell
    Wang, Hongtao
    Maurer, Barry J.
    Liu, Yong-Yu
    Wang, Elaine
    Allegood, Jeremy C.
    Kelly, Samuel
    Symolon, Holly
    Liu, Ying
    Merrill, Alfred H., Jr.
    Gouaze-Andersson, Valerie
    Yu, Jing Yuan
    Giuliano, Armando E.
    Cabot, Myles C.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (09) : 2967 - 2976
  • [48] Cyclosporin a enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cells
    Lim, SJ
    Simeone, AM
    Kim, CK
    Tari, AM
    INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (03) : 243 - 247
  • [49] EFFECTS OF N-(4-HYDROXYPHENYL)RETINAMIDE SUPPLEMENTATION ON VITAMIN-A METABOLISM
    LEWIS, KC
    ZECH, LA
    PHANG, JM
    CANCER RESEARCH, 1994, 54 (15) : 4112 - 4117
  • [50] N-(4-hydroxyphenyl)retinamide activation of a distinct pathway signaling apoptosis
    Dmitrovsky, E
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (16) : 1179 - 1181
12345